カテゴリ： visiongain, 世界, 医療/バイオ

PoC診断のグローバル市場2023-2033：グルコースモニタリング、心臓代謝モニタリング、感染症検査、凝固モニタリング、その他

■ 英語タイトル：Point of Care Diagnostics Market Report 2023-2033 : Forecasts by Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-abuse Testing, Fecal Occult Testing, Other), by Mode (Prescription-based, OTC), by Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, Other), by Platform (Lateral Flow Assay, Dipstick, Microfluidics, Molecular Diagnostics, Immunoassay), by End-user (Clinics, Hospitals, Home Care Setting, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

調査会社visiongain社が発行したリサーチレポート（データ管理コード：VGA23FB007）■ 発行会社/調査会社：visiongain
■ 商品コード：VGA23FB007
■ 発行日：2023年1月3日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：352
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※visiongain社発行の調査レポートは、Single UserとDept Licence(Five User)の場合、DRM（デジタル著作権管理）付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※visiongain社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[PoC診断のグローバル市場2023-2033：グルコースモニタリング、心臓代謝モニタリング、感染症検査、凝固モニタリング、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Visiongain社の本調査資料は、世界のPoC診断市場規模が2033年までにCAGR 8.8%で成長すると推測しています。本資料は、PoC診断の世界市場について幅広く調査を行い、レポート概要、エグゼクティブサマリー、市場動向、製品別（グルコースモニタリング、心臓代謝モニタリング、感染症検査、凝固モニタリング、その他）分析、モード別（処方箋ベース製品、OTC製品）分析、試料別（血液、鼻＆中咽頭スワブ、尿、その他）分析、プラットフォーム別（ラテラルフローアッセイ、ディップスティック、マイクロフルイディクス、分子診断、イムノアッセイ）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報など、以下のようにまとめています。尚、Abbott、AccuBioTech Co., Ltd、BD、bioMerieux SA、Chembio Diagnostics, Inc.、Danaher、EKF Diagnostics、F. Hoffmann-La Roche Ltd、Fluxergy 、LumiraDx、Meridian Bioscience、Nipro Europe Group Companies、Nova Biomedical、Orasure Technologies, Inc.などの企業情報を含んでいます。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界のPoC診断市場規模：製品別
- グルコースモニタリングの市場規模
- 心臓代謝モニタリングの市場規模
- 感染症検査の市場規模
- 凝固モニタリングの市場規模
- その他製品の市場規模
・世界のPoC診断市場規模：モード別
- 処方箋ベース製品における市場規模
- OTC製品における市場規模
・世界のPoC診断市場規模：試料別
- 血液PoC診断の市場規模
- 鼻＆中咽頭スワブPoC診断の市場規模
- 尿PoC診断の市場規模
- その他試料の市場規模
・世界のPoC診断市場規模：プラットフォーム別
- ラテラルフローアッセイの市場規模
- ディップスティックの市場規模
- マイクロフルイディクスの市場規模
- 分子診断の市場規模
- イムノアッセイの市場規模
・世界のPoC診断市場規模：地域別
- 北米のPoC診断市場規模
- ヨーロッパのPoC診断市場規模
- アジア太平洋のPoC診断市場規模
- 中南米のPoC診断市場規模
- 中東・アフリカのPoC診断市場規模
・企業情報

The Point of Care Diagnostics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Incidence of Target Conditions and Rising Number of CLIA Waived POC Tests Are Driving the Market Growth
Target conditions for POC testing are illnesses or disorders that require ongoing monitoring, such as diabetes, hemophilia, cancer, and cardiac problems. The adoption of POC testing equipment can therefore be attributed in large part to the rising incidence and prevalence of these illnesses. Diabetes is a serious, chronic disorder that can significantly affect people’s lives, wellbeing, and families all around the world. According to IDF, in 2021, there were 537 million diabetics worldwide between the ages of 20 and 79.

CLIA defines waived tests as straightforward laboratory investigations and procedures with a very low chance of producing an erroneous result. In addition to approving manufacturer petitions for test system waivers, the Food and Drug Administration (FDA) determines what standards testing must follow in terms of being simple and error prone. The Binx health io CT/NG test, a molecular platform used to detect STDs such as chlamydia and gonorrhea at the point of treatment, acquired a CLIA waiver from the US FDA in April 2021, according to a statement released at the time

Stringent and Time-Consuming Regulatory Policies Likely to Challenge Market Growth
The complicated FDA regulations and CLIA laboratory standards present manufacturers with some regulatory challenges despite the rising demand for POC equipment (for the premarket approval of POC testing kits). Manufacturers must provide performance data to the FDA for any new POC equipment to be approved in the United States. This should show that people and healthcare professionals can use these tools and get outcomes that are comparable to those of clinical laboratory tests. For in vitro diagnostic (IVD) equipment as opposed to non-IVD ones, the amount of examination is also rather exceptional. For instance, the FDA typically waits until the intended application, conditions for usage, target patient demographic, and test performance characteristics remain intact before re-examining approved prescription non-IVD devices for use in new situations. Though under this rule POC devices are not covered.

What Questions Should You Ask before Buying a Market Research Report?
• How is the point of care diagnostics market evolving?
• What is driving and restraining the point of care diagnostics market?
• How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each point of care diagnostics submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading point of care diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the point of care diagnostics projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of point of care diagnostics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the point of care diagnostics market?
• Where is the point of care diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the point of care diagnostics market today, and over the next 10 years:
• Our 352-page report provides 158 tables, 225 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the point of care diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising point of care diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product
• Glucose Monitoring
• Cardiometabolic Monitoring
• Infectious Disease Testing
• Coagulation Monitoring
• Pregnancy & Fertility Testing
• Tumor/Cancer Marker Testing
• Urinalysis Testing
• Cholesterol Testing
• Hematology Testing
• Drugs-of-abuse Testing
• Fecal Occult Testing
• Other POC Products

Mode
• Prescription-based
• OTC

Sample
• Blood
• Nasal and Oropharyngeal Swabs
• Urine
• Other

Platform
• Lateral Flow Assay
• Dipstick
• Microfluidics
• Molecular diagnostics
• Immunoassay

End User
• Clinics
• Hospitals
• Home Care Setting
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Point of Care Diagnostics Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott
• AccuBioTech Co., Ltd
• BD
• bioMerieux SA
• Chembio Diagnostics, Inc.
• Danaher
• EKF Diagnostics
• F. Hoffmann-La Roche Ltd
• Fluxergy
• LumiraDx
• Meridian Bioscience
• Nipro Europe Group Companies
• Nova Biomedical
• Orasure Technologies, Inc.
• PTS Diagnostics
• Qiagen
• Quidel Corporation
• Response Biomedical
• Sekisui Diagnostics
• Siemens Healthcare GmbH
• Spectral Medical Inc.
• Thermo Fisher Scientific Inc.
• Trinity Biotech Ireland
• Trividia Health, Inc.
• Werfen

Overall world revenue for Point of Care Diagnostics Market, 2023 to 2033 in terms of value the market will surpass US$43 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Point of care diagnostics Market, 2023 to 2033 report help you?
In summary, our 350+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Point of Care Diagnostics Market, 2023 to 2033 Market, with forecasts for product, mode, sample, platform, end user, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 18 key national markets – See forecasts for the Point of Care Diagnostics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Netherlands, China, India, Japan, Australia, South Korea, Brazil, GCC, and South Africa among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 25 of the major companies involved in the Point of Care Diagnostics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Point of Care Diagnostics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

*** レポート目次（コンテンツ）***

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Point of Care Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 High Prevalence of Infectious Diseases Across the Globe
3.2.1.2 Increasing Incidence of Target Conditions
3.2.1.3 Growing Government Support
3.2.1.4 Rising Number of CLIA Waived POC Tests
3.2.2 Market Restraining Factors
3.2.2.1 Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
3.2.2.2 Stringent and Time-Consuming Regulatory Policies
3.2.3 Market Opportunities
3.2.3.1 POC Tests with Multiplexing Capabilities
3.2.3.2 Healthcare Decentralization – Converting Lab Tests to POC Tests
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Low Bargaining Power of Supplier
3.4.2 High Bargaining Power of Buyer
3.4.3 Low Threat of New Entrants
3.4.4 High Threat of Substitutes
3.4.5 High Intensity of Competitive Rivalry
3.5 PEST Analysis
3.6 SWOT Analysis

4 Point of Care Diagnostics Market, by Product, 2023-2033
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Point of Care Diagnostics Market Size Estimation and Forecast by Product
4.4 Glucose Monitoring
4.4.1 Market Size by Region, 2023-2033 (US$ bn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Cardiometabolic Monitoring
4.5.1 Market Size by Region, 2023-2033 (US$ bn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Infectious Disease Testing
4.6.1 Market Size by Region, 2023-2033 (US$ bn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Coagulation Monitoring
4.7.1 Market Size by Region, 2023-2033 (US$ bn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Pregnancy & Fertility Testing
4.8.1 Market Size by Region, 2023-2033 (US$ bn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Tumour/Cancer Marker Testing
4.9.1 Market Size by Region, 2023-2033 (US$ bn)
4.9.2 Market Share by Region, 2023 & 2033 (%)
4.10 Urinalysis Testing
4.10.1 Market Size by Region, 2023-2033 (US$ bn)
4.10.2 Market Share by Region, 2023 & 2033 (%)
4.11 Cholesterol Testing
4.11.1 Market Size by Region, 2023-2033 (US$ bn)
4.11.2 Market Share by Region, 2023 & 2033 (%)
4.12 Hematology Testing
4.12.1 Market Size by Region, 2023-2033 (US$ bn)
4.12.2 Market Share by Region, 2023 & 2033 (%)
4.13 Drugs-of-abuse Testing
4.13.1 Market Size by Region, 2023-2033 (US$ bn)
4.13.2 Market Share by Region, 2023 & 2033 (%)
4.14 Fecal Occult Testing
4.14.1 Market Size by Region, 2023-2033 (US$ bn)
4.14.2 Market Share by Region, 2023 & 2033 (%)
4.15 Other POC Products
4.15.1 Market Size by Region, 2023-2033 (US$ bn)
4.15.2 Market Share by Region, 2023 & 2033 (%)

5 Point of Care Diagnostics Market, by Mode, 2023-2033
5.1 Key Findings
5.2 Mode Segment: Market Attractiveness Index
5.3 Point of Care Diagnostics Market, by Mode
5.4 Prescription-based Products
5.4.1 Market Size by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Over the Counter (OTC) Products
5.5.1 Market Size by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Point of Care Diagnostics Market, by Sample, 2023-2033
6.1 Key Findings
6.2 Sample Segment: Market Attractiveness Index
6.3 Point of Care Diagnostics Market Size Estimation and Forecast by Sample
6.4 Blood
6.4.1 Market Size by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Nasal and Oropharyngeal Swabs
6.5.1 Market Size by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Urine
6.6.1 Market Size by Region, 2023-2033 (US$ bn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Other
6.7.1 Market Size by Region, 2023-2033 (US$ bn)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Point of Care Diagnostics Market, by Platform, 2023-2033
7.1 Key Findings
7.2 Platform Segment: Market Attractiveness Index
7.3 Point of Care Diagnostics Market Size Estimation and Forecast by Platform
7.4 Lateral Flow Assay
7.4.1 Market Size by Region, 2023-2033 (US$ bn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Dipstick
7.5.1 Market Size by Region, 2023-2033 (US$ bn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Microfluidics
7.6.1 Market Size by Region, 2023-2033 (US$ bn)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Molecular diagnostics
7.7.1 Market Size by Region, 2023-2033 (US$ bn)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Immunoassay
7.8.1 Market Size by Region, 2023-2033 (US$ bn)
7.8.2 Market Share by Region, 2023 & 2033 (%)

8 Point of Care Diagnostics Market, by End User, 2023-2033
8.1 Key Findings
8.2 End User Segment Market Attractiveness Index
8.3 Point of Care Diagnostics Market Size Estimation and Forecast by End User
8.4 Clinics
8.4.1 Market Size by Region, 2023-2033 (US$ bn)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Hospitals
8.5.1 Market Size by Region, 2023-2033 (US$ bn)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Home Care Settings
8.6.1 Market Size by Region, 2023-2033 (US$ bn)
8.6.2 Market Share by Region, 2023 & 2033 (%)
8.7 Other End-users
8.7.1 Market Size by Region, 2023-2033 (US$ bn)
8.7.2 Market Share by Region, 2023 & 2033 (%)

9 Point of Care Diagnostics Market Analysis by Region, 2023-2033
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Point of Care Diagnostics Market, 2023-2033
10.1 Key Findings
10.2 North America Point of Care Diagnostics Market Attractiveness Index
10.3 North America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
10.4 North America Point of Care Diagnostics Market Forecast by Product
10.5 North America Point of Care Diagnostics Market Forecast by Mode
10.6 North America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
10.7 North America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
10.8 North America Point of Care Diagnostics Market Size Estimation and Forecast by End Users
10.9 North America Point of Care Diagnostics Market Forecast by Country
10.10 U.S. Point of Care Diagnostics Market Analysis
10.11 Canada Point of Care Diagnostics Market Analysis

11 Europe Point of Care Diagnostics Market, 2023-2033
11.1 Key Findings
11.2 Europe Point of Care Diagnostics Market Attractiveness Index
11.3 Europe Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
11.4 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Country
11.5 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Product
11.6 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Mode
11.7 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Sample
11.8 Europe Point of Care Diagnostics Market Size Estimation and Forecast by Platform
11.9 Europe Point of Care Diagnostics Market Size Estimation and Forecast by End-users
11.10 Germany Point of Care Diagnostics Market Analysis
11.11 UK Point of Care Diagnostics Market Analysis
11.12 France Point of Care Diagnostics Market Analysis
11.13 Italy Point of Care Diagnostics Market Analysis
11.14 Spain Point of Care Diagnostics Market Analysis
11.15 Netherlands Point of Care Diagnostics Market Analysis
11.16 Rest of Europe Point of Care Diagnostics Market Analysis

12 Asia Pacific Point of Care Diagnostics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Point of Care Diagnostics Market Attractiveness Index
12.3 Asia Pacific Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Country
12.5 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Product
12.6 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Mode
12.7 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Sample
12.8 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by Platform
12.9 Asia Pacific Point of Care Diagnostics Market Size Estimation and Forecast by End-users
12.10 Japan Point of Care Diagnostics Market Analysis
12.11 China Point of Care Diagnostics Market Analysis
12.12 India Point of Care Diagnostics Market Analysis
12.13 Australia Point of Care Diagnostics Market Analysis
12.14 South Korea Point of Care Diagnostics Market Analysis
12.15 Rest of Asia Pacific Point of Care Diagnostics Market Analysis

13 Latin America Point of Care Diagnostics Market Analysis
13.1 Key Findings
13.2 Latin America Point of Care Diagnostics Market Attractiveness Index
13.3 Latin America Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
13.4 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Country
13.5 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Product
13.6 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Mode
13.7 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Sample
13.8 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by Platform
13.9 Latin America Point of Care Diagnostics Market Size Estimation and Forecast by End-users
13.10 Brazil Point of Care Diagnostics Market Analysis
13.11 Mexico Point of Care Diagnostics Market Analysis
13.12 Rest of Latin America Point of Care Diagnostics Market Analysis

14 MEA Point of Care Diagnostics Market Analysis
14.1 Key Findings
14.2 MEA Point of Care Diagnostics Market Attractiveness Index
14.3 MEA Point of Care Diagnostics Market by Country, 2023, 2028 & 2033 (US$ bn)
14.4 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Country
14.5 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Product
14.6 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Mode
14.7 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Sample
14.8 MEA Point of Care Diagnostics Market Size Estimation and Forecast by Platform
14.9 MEA Point of Care Diagnostics Market Size Estimation and Forecast by End-users
14.10 GCC Point of Care Diagnostics Market Analysis
14.11 South Africa Point of Care Diagnostics Market Analysis
14.12 Rest of MEA Point of Care Diagnostics Market Analysis

15 Company Profiles
15.1 Competitive Landscape, 2021
15.2 Abbott
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2017-2021
15.2.3.2 R&D, 2017-2021
15.2.3.3 Regional Market Shares, 2021
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 F. Hoffmann-La Roche Ltd
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2017-2021
15.3.3.2 R&D, 2017-2021
15.3.3.3 Regional Market Shares, 2021
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Quidel Corporation
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2017-2021
15.4.3.2 R&D, 2017-2021
15.4.3.3 Regional Market Shares, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 AccuBioTech Co., Ltd
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Product Benchmarking
15.5.4 Strategic Outlook
15.6 Thermo Fisher Scientific
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2017-2021
15.6.3.2 R&D, 2017-2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 BD
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2017-2021
15.7.3.2 R & D, 2017-2021
15.7.3.3 Regional Market Shares, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Danaher
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2017-2021
15.8.3.2 R&D, 2017-2021
15.8.3.3 Regional Market Shares, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 PTS Diagnostics
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.10 Trinity Biotech Ireland
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2017-2021
15.10.3.2 Regional Market Shares, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Siemens Healthcare GmbH
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2017-2021
15.11.3.2 R&D, 2017-2021
15.11.3.3 Regional Market Shares, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Sekisui Diagnostics
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Product Benchmarking
15.12.4 Strategic Outlook
15.13 Fluxergy
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Product Benchmarking
15.13.4 Strategic Outlook
15.14 Chembio Diagnostics Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2017-2021
15.14.3.2 R&D, 2017-2021
15.14.3.3 Regional Market Shares, 2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Werfen
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2017-2021
15.15.3.2 R&D, 2017-2021
15.15.3.3 Regional Market Shares, 2021
15.15.4 Product Benchmarking
15.16 NOVA BIOMEDICAL
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.17 Qiagen
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2017-2021
15.17.3.2 R&D, 2017-2021
15.17.3.3 Regional Market Shares, 2021
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 bioMerieux SA
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2017-2021
15.18.3.2 R&D, 2017-2021
15.18.3.3 Regional Market Shares, 2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 Nipro Europe Group Companies
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Financial Analysis
15.19.3.1 Net Revenue, 2017-2021
15.19.3.2 R&D, 2017-2021
15.19.3.3 Regional Market Shares, 2021
15.19.4 Product Benchmarking
15.19.5 Strategic Outlook
15.20 EKF Diagnostics Holdings plc
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Financial Analysis
15.20.3.1 Net Revenue, 2017-2021
15.20.3.2 Regional Market Shares, 2021
15.20.4 Product Benchmarking
15.20.5 Strategic Outlook
15.21 TRIVIDIA HEALTH, INC.
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Product Benchmarking
15.22 Spectral Medical Inc.
15.22.1 Company Snapshot
15.22.2 Company Overview
15.22.3 Product Benchmarking
15.23 Orasure Technologies, Inc.
15.23.1 Company Snapshot
15.23.2 Company Overview
15.23.3 Financial Analysis
15.23.3.1 Net Revenue, 2017-2021
15.23.3.2 R&D, 2017-2021
15.23.3.3 Regional Market Shares, 2021
15.23.4 Product Benchmarking
15.23.5 Strategic Outlook
15.24 Response Biomedical
15.24.1 Company Snapshot
15.24.2 Company Overview
15.24.3 Product Benchmarking
15.24.4 Strategic Outlook
15.25 LumiraDX
15.25.1 Company Snapshot
15.25.2 Company Overview
15.25.3 Financial Analysis
15.25.3.1 Net Revenue, 2019-2021
15.25.3.2 R&D, 2019-2021
15.25.4 Product Benchmarking
15.25.5 Strategic Outlook
15.26 Meridian Bioscience Inc.
15.26.1 Company Snapshot
15.26.2 Company Overview
15.26.3 Financial Analysis
15.26.3.1 Net Revenue, 2017-2021
15.26.3.2 R&D, 2017-2021
15.26.3.3 Regional Market Shares, 2021
15.26.4 Product Benchmarking
15.26.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from
16.2 Recommendations for Market Players



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 在宅検査キットのグローバル市場2023：妊娠検査薬、HIV検査キット、糖尿病、感染症検査、血糖検査、排卵予測検査薬、その他
  • 防塵剤のグローバル市場2023～2033（~2033）：湿式防塵剤、乾式防塵剤
  • 心血管装置のグローバル市場2023-2033：高血圧症、心房細動、慢性虚血性心疾患、ストローク、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(VGA23FB007 )"PoC診断のグローバル市場2023-2033：グルコースモニタリング、心臓代謝モニタリング、感染症検査、凝固モニタリング、その他" (英文：Point of Care Diagnostics Market Report 2023-2033 : Forecasts by Product (Glucose Monitoring, Cardiometabolic Monitoring, Infectious Disease Testing, Coagulation Monitoring, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Hematology Testing, Drugs-of-abuse Testing, Fecal Occult Testing, Other), by Mode (Prescription-based, OTC), by Sample (Blood, Nasal and Oropharyngeal Swabs, Urine, Other), by Platform (Lateral Flow Assay, Dipstick, Microfluidics, Molecular Diagnostics, Immunoassay), by End-user (Clinics, Hospitals, Home Care Setting, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis)はvisiongain社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。